---
title: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Impacts Long-Term
  Outcomes After Curative-Intent Surgery for Hepatocellular Carcinoma
date: '2025-02-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39964081/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250218170842&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Patients with HCC undergoing LR and meeting the new MASLD
  criteria have significantly shorter OS. This study provides empirical prognostic
  evidence for the novel MASLD/MetALD classification in a large European cohort of
  patients undergoing curative-intent HCC ...'
disable_comments: true
---
CONCLUSIONS: Patients with HCC undergoing LR and meeting the new MASLD criteria have significantly shorter OS. This study provides empirical prognostic evidence for the novel MASLD/MetALD classification in a large European cohort of patients undergoing curative-intent HCC ...